UBS Group AG - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 31 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q3 2022$14,0000.0%1,3840.0%0.00%
Q2 2022$14,000
+7.7%
1,384
+7.8%
0.00%
Q1 2022$13,000
+18.2%
1,284
+19.0%
0.00%
Q4 2021$11,000
+22.2%
1,079
+22.8%
0.00%
Q3 2021$9,0008790.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Exos Asset Management LLC 50,000$502,0000.39%
Arena Capital Advisors, LLC- CA 300,000$3,020,0000.30%
MMCAP International Inc. SPC 250,000$2,516,0000.25%
PERISCOPE CAPITAL INC. 350,000$3,523,0000.14%
Kepos Capital LP 175,000$1,761,0000.11%
Ghisallo Capital Management LLC 150,000$1,508,0000.10%
Shaolin Capital Management LLC 200,000$2,013,0000.08%
Atalaya Capital Management LP 40,000$402,0000.08%
Radcliffe Capital Management, L.P. 200,000$2,013,0000.08%
GABELLI & Co INVESTMENT ADVISERS, INC. 57,789$581,0000.07%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders